RDY 423 (Ciprofloxacin hydrochloride extended release 1000 mg)
Pill imprint RDY 423 has been identified as Ciprofloxacin hydrochloride extended release 1000 mg.
Ciprofloxacin is used in the treatment of urinary tract infection; bacterial infection; epididymitis, sexually transmitted; sinusitis; gonococcal infection, uncomplicated (and more), and belongs to the drug class quinolones. Risk cannot be ruled out during pregnancy. Ciprofloxacin 1000 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- RDY 423
- Strength:
- 1000 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Quinolones
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dr. Reddy’s Laboratories Inc.
- National Drug Code (NDC):
- 55111-0423
- Inactive Ingredients:
- crospovidone
silicon dioxide
ethylcelluloses
hypromelloses
magnesium stearate
polyethylene glycol 400
succinic acid
titanium dioxide
More about ciprofloxacin
Consumer resources
- Ciprofloxacin
- Ciprofloxacin extended-release tablets
- Ciprofloxacin suspension
- Ciprofloxacin tablets
- Ciprofloxacin injection
- More (2) »
- Other brands: Cipro, Cipro I.V., Cipro XR, Proquin XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
